Saturday, October 31, 2026

Nikola Stock Went Down By Over 27% In The Last 5 Sessions

ViaNews Editorial Team

August 11, 2023

Nikola Stock Went Down By Over 27% In The Last 5 Sessions

Introduction to Nikola Corporation's recent financial performance and market trends. Nikola Corporation (NASDAQ:NKLA), an energy and transportation solutions innovator, saw its shares tumble 27.2% over five sessions ending Friday. Despite general upward trends on NASDAQ, its share price declined significantly while only minimally decreasing by 0.58% overall.

Nikola's Share Price Performance

Nikola's closing price in its last session was 78.15% below its 52-week high, prompting investors to be alarmed at its potential volatility.

Nikola's Financial Health

Nikola's financial metrics reveal a strikingly complex picture. Although its trailing twelve month earnings per share (EPS) reached 1.4, its return on equity (ROE), which measures profitability relative to shareholder's equity, was alarmingly negative at -137.05% - meaning that Nikola incurred substantial losses relative to each dollar invested over time.

The Challenge Facing Nikola

Nikola's earnings before interest, taxes, depreciation and amortization (EBITDA) stands at -6.04, reflecting its inability to generate operational earnings and its negative return on equity (ROE). Together these numbers demonstrate serious financial challenges facing Nikola.

Nikola's Growth Estimations

Nikola's growth estimates for this and future quarters have been set at 12% and 35.7%, respectively. If these targets are achieved, it could potentially reignite Nikola's struggling stock.

Nikola's Share Price Movement

Nikola's share price stands out in comparison with its 50-day and 200-day moving averages, suggesting it has experienced substantial short-term upward movement, yet remains down in the long run, reinforcing its instability.

Investor Considerations

Potential Nikola investors should proceed with caution. Nikola's stock exhibits high levels of volatility and financial insecurity, though its projected growth estimates may provide some compensation for these risks.

More news about Nikola (NKLA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com